We have found an increased immunohistochemical expression of STING in 75% (24/32) of metastatic or locally aggressive clear cell renal cell carcinomas in contrast to clinically indolent ones (23%, 26 of 114 tumors). The gene discussed is STING1; the disease is clear cell renal carcinoma.